Characterization of rat CD80 and CD86 by molecular cloning and mAb

International Immunology

Volumn 9, Issue 7, 1997, Pages 993-1000

  Maeda, Keiko ^a   Sato, Takeshi ^a   Azuma, Miyuki ^b   Yagita, Hideo ^a,c   Okumura, Ko ^a,c  

^a JUNTENDO UNIVERSITY   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

CD80; CD86; Co stimulatory signal; Rat

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOMA CELL LINE; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION; VIRUS CELL TRANSFORMATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BASE SEQUENCE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CLONING, MOLECULAR; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED LEW; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES;

EID: 0030998407     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.7.993     Document Type: Article

References (48)

1. Mueller, D., Jenkins, M. K. and Schwartz, R. H. 1989. Clonal expansion versus functional inactivation: a co-stimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
2. Robey, E. and Allison, J. P. 1995. T-cell activation: integration of signals from the antigen receptor and co-stimulatory molecules. Immunol. Today 16:306.
3. Linsley, P. S. and Ledbetter, J. A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
4. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
5. Lenshow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/ B7 system of T cell co-stimulation. Annu. Rev. Immunol 14:233.
6. June, C. H., Ledbetter, J. A., Linsley, P. S. and Thompson, C. B. 1990. Role of the CD28 receptor in T-cell activation. Immunol. Today 11:211.
7. Aruffo, A. and Seed, B. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl Acad. USA. 84:8573.
8. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F. and Nadler, L. M. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
9. Linsley, P. S., Clark, E. A. and Ledbetter, J. A. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl Acad. Sci. USA. 87:5031.
10. Azuma, M., Ito, D., Yagita, H., Okumura, O., Phillips, J. H., Lainer, L. L. and Sozoma, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
11. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr. Lombard, L. A., Gray, G. S. and Nadler, L. M. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that co-stimulates human T cell proliferation. Science 262:909.
12. Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvard, M., Bradshaw, J., Ledbetter, J. A. and Linsley, P. S. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165.
13. Chen, C., Gault, A., Shen, L. and Nabavi, N. 1994. Molecular cloning and expression of early T cell co-stimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 152:4929.
14. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., Laszlo, G., Lombard, L. A., Wang, S., Gray, G. S., Nadler, L. M. and Sharpe, A. H. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that co-stimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185.
15. Razi-Wolf, Z., Freeman, G. J., Calvin, F., Benacerraf, B., Nadler, L. and Reiser, H. 1992. Expression and function of the murine B7 antigen, the major co-stimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA. 89:4210.
16. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J., Ledbetter, J. A., Singh, C. and Tepper, M. A. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
17. Nuriya, S., Yagita, H., Okumura, K. and Azuma, M. 1996. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int. Immunol. 8:917.
18. Saito, K., Yagita, H., Hashimoto, H., Okumura, K. and Azuma, M. 1996. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease. Eur. J. Immunol. 26:3098.
19. Via, C. S., Rus, V., Nguyen, P., Linsley, P. and Gause, W. C. 1996. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development. CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J. Immunol. 157:4258.
20. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. F. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
21. Bashuda, H., Seino, K., Kano, M., Sato, K., Azuma, M., Yagita, H. and Okumura, K. 1996. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Transplant. Proc. 28:1039.
22. Finck, B. K., Linsley, P. S. and Wofsy, D. 1994. Treatment of murine lupus with CTLA4Ig. Science. 265:1225.
23. Nakajima, A., Azuma, M., Kodera, S., Nuriya, S., Terashi, A., Abe, M., Hirose, S., Shirai, S., Yagita, H. and Okumura, K. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur. J. Immunol. 25:3060
24. Webb, L. M., Walmsley, M. J. and Feldmann, M. 1996. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur. J. Immunol. 26:2320.
25. Miller, S. D., Vanderlugt, C. L., Lenschow, D. J., Pope, J. G., Karandikar, N. J., Dal Canto, M. C. and Bluestone, J. A. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
26. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
27. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Navabi, N. and Glimcher, L. H. 1995. B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
28. Thompson, C. B. 1995. Distinct roles for the co-stimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979.
29. Barney-Knoerzer, D., Karr, R. W., Schwartz, B. D. and Mengle-Gaw, L. J. 1995. Collagen-induced arthritis in the BB rat: prevention of disease by treatment with CTLA-4-Ig. J. Clin. Invest. 96:987.
30. Levine, S. and Wenk, E. J. 1964. Allergic encephalomyelitis: a hyperacute form. Science 146:1681.
31. Ishiguro, N., Abe, M., Seto, K., Sakurai, H., Ikeda, H., Wakisaka, A., Togashi, T., Tateno, M. and Yoshiki, T. 1992. A rat model of human T lymphocyte virus type 1 (HTLV-1) infection. 1. Humoral antibody response, provirus integration, and HTLV-1-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-1 carrier rats. J. Exp. Med. 176:981.
32. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R.-Q., Gibson, M. L., Zheng, X.-G., Myrdal, S., Gordon, D., Bailey, T., Bolling, S. F. and Thompson, C. B. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl Acad. Sci. USA 89:11102.
33. Arima, T., Rehman, A., Hickey, W. F. and Flye, M. W. 1996. Inhibition by CTLA4Ig of experimental allergic encephalomyelitis. J. Immunol. 156:4916.
34. Tateno, M., Kondo, N., Itoh, T., Chubachi, T., Togashi, T. and Yoshiki, T. 1984. Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization. J. Exp. Med. 159:1105.
35. Kinebuchi, M., Ide, T., Lupin, D., Tamatani, T., Miyasaka, M., Mastuura, A., Nagai, Y., Kikuchi, K. and Uede, T. 1991. A novel cell surface antigen involved in thymocyte and thymic epithelial cell adhesion. J. Immunol. 146:3721.
36. Kobayashi, M., Nagayasu, H., Hamada, J., Takeichi, N. and Hosokawa, M. 1994. ONO-4007, a synthetic lipid A derivative, induces differentiation of rat myelomonocytic leukemia cells in vitro and in vivo. Exp, Hematol. 22:454.
37. Lane, P., Gerharg, W., Hubele, S., Lanzavecchia, A. and McConnell, F. 1993. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1. Immunology 80:56.
38. Judge, T. A., Liu, M., Christensen, P. J., Fak, J. J. and Turka, L. A. 1995. Cloning the rat homolog of the CD28/CTLA4-ligand B7-1: structural and functional analysis. Int. Immunol. 7:171.
39. Freeman, G. J., Gray, G. S., Gimmi, C. D., Lombard, D. B., Zhou, L.-J., White, M., Fingeroth, J. D., Gribben, J. G. and Nadler, L. M. 1991. Structure, expression, and T cell co-stimulatory activity of the murine homologue of the B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
40. Valle, A., Garrone, P., Yssel, H., Bonnefoy, J. Y., Freedman, A. S., Freeman, G., Nadler, L. M. and Banchereau, J. 1990. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1 transformed T cells. Immunology 69:531.
41. Lal, R. B., Rudolph, D. L., Dezzutti, C. S., Linsley, P. S. and Prince, H. E. 1996. Co-stimulatory effects of T cell proliferation during infection with human T lymphotropic virus type I and II are mediated through CD80 and CD86 ligands. J. Immunol. 157:1288.
42. Yoshida, M. and Fijisawa, J. 1992. Positive and negative regulation of HTLV-1 gene expression and their roles in leukemogenesis. Gann Monogr. Cancer Res. 39:217.
43. Suzuki, T., Hirai, H., Murakami, T. and Yoshida, M. M. 1995. Tax protein of HTLV-1 destabilizes the complexes of NF-κB and IκB-a and induces nuclear translocation of NF-κB for transcriptional activation. Oncogene 10:1199.
44. Zhao, J.-I., Freeman, G. J., Gray, G. S., Nadlar, L. M. and Glimcher, L. H. 1996. A cell type-specific enhancer in the human B7. 1 gene regulated by NF-κB. J. Exp. Med. 183:777.
45. Nagata, K., Ohtani, K., Nakamura, M. and Sugamura, K. 1989. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J. Virol. 63:3220.
46. Yamada, S., Ikeda, H., Yamazaki, H., Shikishima, H., Kikuchi, K., Wakisaka, A., Kasai, N., Shimotohno, K. and Yoshiki, T. 1995. Cytokine-producing mammary carcinoma in transgenic rats carrying the pX gene of Human T-Lymphotropic Virus type 1. Cancer Res. 55:2524.
47. Prince, H. E., York, J., Golding, J., Owen, S. M. and Lal, R. B. 1994. Spontaneous lymphocyte proliferation in HTLV-I and HTLV-II infection: T cell subset response and their relationship to presence of provirus and viral antigen production. Clin. Diag. Lab. Immunol. 1:273.
48. Höllesberg, P. and Hafler, D. A. 1993. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173.